As shown in S7 and S8 Tables, the PNPLA3 rs738409 (C/G) and TM6SF2 rs58542926 (C/T) genotypes demonstrated no effects on liver steatosis and dyslipidemia at baseline and SVR24. This evidence concerns the gene PNPLA3 and metabolic syndrome.